Nkarta, Inc.

International Women’s Day (#IWD2025) recognizes the incredible women whose impactful contributions inspire us each day. Recently, we were honored to host Robin Toft, who shared her insights in a presentation titled, "Authenticity and developing skills around how to be one's best self and advance in all areas of life." Thank you to Robin for your inspiring presentation and thank you to the women at Nkarta for all that you do to make #NKcell therapy accessible to people who need it!?

Our own Loan Hoang, Sr. Director of Quality Assurance, will be speaking at the upcoming ISPE San Francisco | Bay Area Chapter's 5th Annual Women in Biotech Frontiers event. This event celebrates the contributions of women in #biotech.?

We recently announced that?enrollment is open in our Ntrust-2 clinical trial for NKX019, an NK-cell therapy candidate engineered to deplete CD19-positive cells in B-cell mediated disease. Our mission is to provide patients in this area of unmet need in #autoimmune disease with more treatment options.?

This International Day of Women and Girls in Science, we’re celebrating the incredible #womeninstem at Nkarta, who are pushing the boundaries of science and making an impact in NK cell therapy development. Thank you for your dedication and inspiring work!???

In case you missed it, our President?Nadir Mahmood, Ph.D., recently joined industry leaders at #FierceJPMWeek 2025 in a panel discussing the evolving landscape of #celltherapy. Read more about?Dr. Mahmood's insights on CAR NK cell therapies for autoimmune diseases and Nkarta's patient-centric approach.?

February marks #BlackHistoryMonth and celebrates the tremendous achievements and contributions of the Black community throughout history. We are grateful for those who have paved an innovative path forward and helped to make the future brighter.?

We are building a pipeline of future cell therapies through our ongoing research and clinical trial initiatives focused on #autoimmune disease, Ntrust1 and Ntrust2. Our goal is to provide patients in this area of unmet need with more treatment options. Read more: https://lnkd.in/etkAqz-F??

By harnessing the body’s #NKcells – the immune system’s first responders – we aim to explore a safer, more tolerable and accessible treatment option to people living with #autoimmune diseases. Learn more about our clinical trial offerings: https://lnkd.in/etkAqz-F??

We are pleased to share that our President, Nadir Mahmood, Ph.D., is participating in a panel at Fierce Life Sciences Events #FierceJPMWeek 2025. This event addresses the latest updates in #celltherapy, the centerpiece of our patient-first approach. Dr. Mahmood and fellow industry leaders will share insights on navigating regulatory hurdles, optimizing manufacturing, and leveraging emerging technologies to address additional disease states. Learn more: https://lnkd.in/dNCikKRB??

We're excited to kick off 2025 at the Informa Connect #BiotechShowcase! Our CEO, Paul Hastings, is moderating a panel addressing healthcare equity and access. Alongside fellow #lifescience industry leaders, he will dive into how innovative solutions in biopharma can support healthcare access and equity. Learn more: https://lnkd.in/ggV8JqPf?